Kazia Therapeutics Ltd
ASX:KZA
Kazia Therapeutics Ltd
ASX:KZA
Price:
0.08 AUD
Market Closed
Updated:
May 2, 2024
Kazia Therapeutics Ltd
Cash from Operating Activities
|
Kazia Therapeutics Ltd
Cash from Operating Activities Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Kazia Therapeutics Ltd
ASX:KZA
|
Cash from Operating Activities
-AU$15.2m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-6%
|
|
|
Immutep Ltd
ASX:IMM
|
Cash from Operating Activities
-AU$35.4m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-10%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Operating Activities
-$59.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Cash from Operating Activities
$2.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Operating Activities
AU$42.3m
|
CAGR 3-Years
31%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Operating Activities
AU$23.9m
|
CAGR 3-Years
130%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kazia Therapeutics Ltd's Cash from Operating Activities?
Cash from Operating Activities
-15.2m
AUD
-15.2m
AUD
Based on the financial report for Jun 30, 2023, Kazia Therapeutics Ltd's Cash from Operating Activities amounts to -15.2m AUD.
What is Kazia Therapeutics Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-6%
-6%
Over the last year, the Cash from Operating Activities growth was 33%. The average annual Cash from Operating Activities growth rates for Kazia Therapeutics Ltd have been -20% over the past three years , -12% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
